Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway

Journal of Experimental and Clinical Cancer Research

Volumn 34, Issue 1, 2015, Pages

  Zhou, Jianping ^a,b   Zhi, Xiaofei ^c   Wang, Linjun ^a   Wang, Weizhi ^a   Li, Zheng ^a   Tang, Jie ^a   Wang, Jiwei ^a   Zhang, Qun ^a   Xu, Zekuan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

EGFR; LncRNA; PI3K; RNA pull down; Xenograft transplantation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LINC00152 PROTEIN; LONG UNTRANSLATED RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; BAGG ALBINO MOUSE; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN RNA BINDING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA IMMUNOPRECIPITATION ASSAY; RNA PULL DOWN ASSAY; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING; XENOTRANSPLANTATION; ANIMAL; CELL TRANSFORMATION; CYTOPLASM; DISEASE MODEL; GENETICS; METABOLISM; PATHOLOGY; RNA TRANSPORT; STOMACH TUMOR; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYTOPLASM; DISEASE MODELS, ANIMAL; HETEROGRAFTS; HUMANS; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA TRANSPORT; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR BURDEN;

EID: 84946063024     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/s13046-015-0250-6     Document Type: Article

References (22)

1. Herszenyi L, Tulassay Z. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci. 2010;14(4):249-58.
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. doi: 10.1002/ijc.29210.
3. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol. 2009;71(2):127-64. doi: 10.1016/j.critrevonc.2009.01.004.
4. Vogiatzi P, Vindigni C, Roviello F, Renieri A, Giordano A. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J Cell Physiol. 2007;211(2):287-95. doi: 10.1002/jcp.20982.
5. Zhao W, Dong S, Duan B, Chen P, Shi L, Gao H, et al. HOTAIR is a predictive and prognostic biomarker for patients with advanced gastric adenocarcinoma receiving fluorouracil and platinum combination chemotherapy. Am J Transl Res. 2015;7(7):1295-302.
6. Pinheiro H, Bordeira-Carrico R, Seixas S, Carvalho J, Senz J, Oliveira P, et al. Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum Mol Genet. 2010;19(5):943-52. doi: 10.1093/hmg/ddp537.
7. Tang J, Zhuo H, Zhang X, Jiang R, Ji J, Deng L, et al. A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma. Cell Death Dis. 2014;5:e1549. doi: 10.1038/cddis.2014.518.
8. Tang J, Jiang R, Deng L, Zhang X, Wang K, Sun B. Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma. Oncotarget. 2015;6(6):4505-15.
9. Wang Y, Wu P, Lin R, Rong L, Xue Y, Fang Y. LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia. Sci Rep. 2015;5:13749. doi: 10.1038/srep13749.
10. Zhuo H, Tang J, Lin Z, Jiang R, Zhang X, Ji J, et al. The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma. Mol Carcinog. 2015. doi: 10.1002/mc.22270.
11. Shen J, Siegel AB, Remotti H, Wang Q, Shen Y, Santella RM. Exploration of Deregulated Long Non-Coding RNAs in Association with Hepatocarcinogenesis and Survival. Cancers (Basel). 2015;7(3):1847-62. doi: 10.3390/cancers7030865.
12. Merry CR, Forrest ME, Sabers JN, Beard L, Gao XH, Hatzoglou M, et al. DNMT1-associated long non-coding RNAs regulate global gene expression and DNA methylation in colon cancer. Hum Mol Genet. 2015. doi: 10.1093/hmg/ddv343.
13. Yoon JH, Abdelmohsen K, Kim J, Yang X, Martindale JL, Tominaga-Yamanaka K, et al. Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination. Nat Commun. 2013;4:2939. doi: 10.1038/ncomms3939.
14. Zhao J, Liu Y, Zhang W, Zhou Z, Wu J, Cui P, et al. Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer. Cell Cycle. 2015:1-12. doi: 10.1080/15384101.2015.1078034.
15. Li Q, Shao Y, Zhang X, Zheng T, Miao M, Qin L, et al. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer. Tumour Biol. 2015;36(3):2007-12. doi: 10.1007/s13277-014-2807-y.
16. Tang W, Tang J, He J, Zhou Z, Qin Y, Qin J, et al. SLIT2/ROBO1-miR-218-1-RET/PLAG1: a new disease pathway involved in Hirschsprung's disease. J Cell Mol Med. 2015;19(6):1197-207. doi: 10.1111/jcmm.12454.
17. Muller S, Raulefs S, Bruns P, Afonso-Grunz F, Plotner A, Thermann R, et al. Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer. Mol Cancer. 2015;14:94. doi: 10.1186/s12943-015-0358-5.
18. Li J, Wang X, Tang J, Jiang R, Zhang W, Ji J, et al. HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma. Cell Physiol Biochem. 2015;37(2):687-96. doi: 10.1159/000430387.
19. Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang Y, Tang GN, et al. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology. 2013;57(5):1882-92. doi: 10.1002/hep.26195.
20. Patel R, Leung HY. Targeting the EGFR-family for therapy: biological challenges and clinical perspective. Curr Pharm Des. 2012;18(19):2672-9.
21. Weng X, Zhang H, Ye J, Kan M, Liu F, Wang T, et al. Hypermethylated Epidermal growth factor receptor (EGFR) promoter is associated with gastric cancer. Sci Rep. 2015;5:10154. doi: 10.1038/srep10154.
22. Nam HJ, Ching KA, Kan J, Kim HP, Han SW, Im SA, et al. Evaluation of the antitumor effects and mechanisms of PF00299804, a pan-HER inhibitor, alone or in combination with chemotherapy or targeted agents in gastric cancer. Mol Cancer Ther. 2012;11(2):439-51. doi: 10.1158/1535-7163.MCT-11-0494.